Targeting Bone Remodeling For the Treatment of Osteoporosis
Targeting Bone Remodeling For the Treatment of Osteoporosis
批准号:
7533252
负责人:
JOHN P BILEZIKIAN
金额:
$0.3万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-17 至 2008-02-28
关键词:
AgingAmericanAreaBiologyBiomechanicsBone GrowthBone remodelingCellsClinicalClinical ResearchDisciplineDiseaseDreamsEnd PointEndocrinologyEngineeringFamilyFertilizationFractureFunctional disorderFutureGeneticHeartHousingImageImmunologyInstitutesKnowledgeLeadMechanicsMineralsModelingMolecularMolecular and Cellular BiologyOrganOsteoblastsOsteoclastsOsteocytesOsteoporosisPathway interactionsPharmaceutical PreparationsPhysiologyPlayProcessPurposeResearchResearch PersonnelRheumatologyRiskRoleScienceScientistShapesSignal PathwaySignal TransductionSkeletonSocietiesSystemTherapeuticThinkingTimeTranslatingUnited States National Institutes of HealthWorkabstractingaging populationbonebone cellbone losscareerconceptdisabilitygenetic epidemiologyimprovedinsightnovelnovel therapeuticspreventprogramssizeskeletal disorder
中文摘要
点击翻译按钮获取中文摘要
英文摘要
6. PROJECT SUMMARY/ABSTRACT
This is a time of great excitement in the field of bone biology. In the past several years, we have
gained great insight into how bone models and remodels, and this information has been applied
to the treatment of osteoporosis and related skeletal disorders. Such knowledge has extended
itself into areas that just a few years ago would have been incomprehensible. For example, the
family of bone cells themselves, the osteoblast and the osteoclast, formerly thought to work in
concert within the bone remodeling unit, now have been joined by the osteocyte, a cell newly
recognized to play a pivotal role in signaling these cells and other systems. Products of these
bone cells, also newly recognized, are identifying processes and mechanisms that extend to the
very heart of molecular control mechanisms. This new knowledge has spanned a wide spectrum
of disciplines that include cell and molecular biology, genetics, epidemiology, engineering,
biomechanics, imaging, material sciences, immunology, and integrative organ physiology. Along
with traditional areas that have housed the discipline, such as endocrinology and rheumatology,
the field is now enriched with cross fertilization from these other areas, leading to new ideas and
new knowledge. It is appropriate at this time, therefore, to hold a meeting in which these
advances can be considered and in which experts in these various areas can gather together.
The idea is to generate even more exciting ideas and therapeutic approaches to osteoporosis,
which is a major cause of disability in our aging population.
We believe it is important at this time to bring together clinical, basic and translational
investigators to discuss these new advances with a view that will have therapeutic relevance.
The proposed meeting will serve as an important step towards translating new knowledge into
new therapeutic concepts. In addition, this meeting will identify key questions for future
research.
The American Society for Bone and Mineral Research is the premier society for the study and
advancement of basic and clinical research in disorders relating to the skeleton. The
considerations described above make it very clear that this is the time for senior thought
leaders, mid-career investigators and young investigators to gather together in concert with NIH
Institutes' staff. Information derived from the exchanges at such a meeting will serve to provide
the NIH with novel ideas about programs worthy of support in future years and lead to a vibrant
exchange of ideas and a definition of vital pathways for future advances in research and
treatment. 7. PROJECT NARRATIVE
Over the last several years, scientists from many different disciplines have contributed to an
astonishingly fast improvement in our knowledge of bone modeling and bone remodeling. We
understand, in ways never dreamed of several decades ago, how bone achieves its size and
shape; how it adapts to changes in mechanical forces; how it senses the need to renew itself by
breaking down old bone and replacing it with new bone within the multi-cellular bone remodeling
unit; what cells, molecules and signaling pathways are involved in bone remodeling. This
knowledge has been translated rapidly into greater understanding of the pathophysiology of
bone loss, underlying genetic factors and elucidation of disease mechanisms. The delivery of
this knowledge to the clinical arena has been nothing short of spectacular with therapeutics that
are transforming how we think of a disease like osteoporosis, that not too long ago was viewed
as an inevitable consequence of aging. Now, we have drugs that can prevent bone loss, can
restore bone mass, can stimulate bone growth, can improve microarchitecture and can achieve
the ultimate end point, the reduction of fracture risk. But, we recognize, at the same time, the
need to understand more completely the skeleton in its complexity so as to make even greater
strides in our attempt to literally cure this disease. The purpose of this meeting is to bring
together experts from these interdisciplinary fields so as to define the direction of the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
17th Fellows Forum on Osteoporosis and Other Metabolic Bone Diseases
-
批准号:10753107
-
项目类别:
-
资助金额:$2.54万
-
财政年份:2023
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
16th Fellows Forum on Osteoporosis and Metabolic Bone Disease
-
批准号:10540535
-
项目类别:
-
资助金额:$2.7万
-
财政年份:2022
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Role of the gut microbiome in the bone loss induced by hyperparathyroidism in mice and humans
-
批准号:10713381
-
项目类别:
-
资助金额:$6.94万
-
财政年份:2021
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Role of the gut microbiome in the bone loss induced by hyperparathyroidism in mice and humans
-
批准号:10679360
-
项目类别:
-
资助金额:$4.18万
-
财政年份:2021
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Role of the gut microbiome in the bone loss induced by hyperparathyroidism in mice and humans
-
批准号:10115891
-
项目类别:
-
资助金额:$57.29万
-
财政年份:2021
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Role of the gut microbiome in the bone loss induced by hyperparathyroidism in mice and humans
-
批准号:10556397
-
项目类别:
-
资助金额:$55.95万
-
财政年份:2021
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
15th Fellows Forum on Osteoporosis and Metabolic Bone Diseases
-
批准号:10318312
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2021
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Role of the gut microbiome in the bone loss induced by hyperparathyroidism in mice and humans
-
批准号:10899018
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2021
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
13th Fellows Forum on Osteoporosis and Metabolic Bone Diseases
-
批准号:9914654
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2019
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Eighth Forum on Osteoporosis and Metabolic Bone Diseases for Fellows in Trai
-
批准号:8784953
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2014
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Seventh Forum on Osteoporosis and Metabolic Bone Diseases for Fellows in Training
-
批准号:8596944
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2013
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Sixth Forum on Osteoporosis and Metabolic Bone Diseases for Fellows in Training
-
批准号:8399283
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2012
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Fifth Forum on Osteoporosis and Metabolic Bone Diseases for Fellows in Training
-
批准号:8204208
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2011
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Targeting Bone Remodeling For the Treatment of Osteoporosis
-
批准号:7407828
-
项目类别:
-
资助金额:$2.7万
-
财政年份:2007
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
BONE PROPERTIES IN HYPOPARATHYROIDISM: EFFECTS OF PTH
-
批准号:6985568
-
项目类别:
-
资助金额:$53.78万
-
财政年份:2005
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
BONE QUALITY IN HYPOPARATHYROIDISM: EFFECTS OF PTH
-
批准号:7205987
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2005
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Treatment of Hypoparathyroidism with Parathyroid Hormone
-
批准号:8135034
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2005
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Bone Properties in Hypoparathyroidism: Effects of PTH
-
批准号:8126488
-
项目类别:
-
资助金额:$60.96万
-
财政年份:2005
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Bone Properties in Hypoparathyroidism: Effects of PTH
-
批准号:8497675
-
项目类别:
-
资助金额:$58.39万
-
财政年份:2005
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
Treatment of Hypoparathyroidism with Parathyroid Hormone
-
批准号:7690909
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2005
-
负责人:JOHN P BILEZIKIAN
-
依托单位:
海外基金